|Day Low/High||92.11 / 95.87|
|52 Wk Low/High||66.93 / 101.73|
The stock has taken a beating, but users of Afrezza are loyal to the drug.
A study of analyst recommendations at the major brokerages shows that Express Scripts Holding Co is the #84 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.
Every January at 'JPM,' investors take the pulse of the biotech industry for the coming year.
Adam Feuerstein compiles a list of questions, thoughts, declarations, catalysts and observations about biotech stocks to help investors prepare for the year ahead.
Kass' trade of the year for 2017 is to short the PowerShares QQQ Trust ETF.
For the first time in three years, Eli Lilly's guidance for next year has topped Wall Street's consensus estimates.
Eli Lilly posts better-than-expected guidance for 2017, sending its share price soaring in premarket trading.
Stocks retreat from records on Wednesday after the Federal Reserve increases its forecasts for next year's rate hikes.
Express Scripts revealed its 2017 financial guidance earlier today, and the Street is hardly enthralled, with shares falling sharply.
Stocks extend losses on Wednesday after the Federal Reserve raises interest rates for the second time in a decade.
Stocks slip Wednesday after a drop in retail sales pulls estimates for fourth-quarter U.S. GDP lower.
There was plenty of shame to spread around, but Theranos CEO Elizabeth Holmes' loathsome mix of arrogance, incompetence and duplicity makes her the Worst CEO of 2016.
The Express Scripts CEO said Wednesday that Trump's impending presidency won't impact guidance for fiscal year 2017.
U.S. stocks lost steam Wednesday, as the markets awaited the Federal Reserve's closely watched rate hike decision.
Stock futures hold mixed on Wednesday morning as producer prices beat forecasts, while retail sales come in below forecasts.
Shares of Eli Lilly were higher Tuesday after announcing that starting January of 2017, customers will be able to purchase insulin at a discount of up to 40%.
Eli Lilly and Express Scripts are seeking to avoid potential bad press over high insulin prices.
Analysts blame drug companies, not pharmacy benefit managers, for the rising cost of drugs.
Shares spiraled downward in early trading, but Mizuho's Irina Koffler expects the stock will plateau by the end of the day.
Jim Cramer says he prefers Celgene to Gilead, and Walgreens Boots Alliance to Express Scripts.
Jim Cramer remains a fan of industrials, transports, banks and domestic oil producers.
PBM stocks are rallying on diminished fears of a drug pricing crackdown, though President-Elect Donald Trump has yet to detail specific proposals.
Consensus estimates for Express Scripts (ESRX) for 2017 seem low, Deutsche Bank says.
Here are Friday's top research calls, including upgrades for Express Scripts and Lions Gate, and downgrades for Qorvo and Whole Foods.
The CEO also suggested that volume-based agreements to determine price would be more effective than pharmacy benefit managers.
Express Scripts (ESRX) late Tuesday posted earnings that topped Wall Street's estimates for the 2016 third quarter.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.